Partner Content Partner Content Chair invite Kerrie Brady & Michael Scherz released ahead of... Invite from Chairs Pain Therapeutics
News Insys settles opioid kickback charges in US, paying out $225... Insys Therapeutics has agreed to pay a hefty $225 million to settle criminal and civil investigations into unlawful marketing practices – including kickbacks – to boost sales of an opioid p
News Mundipharma, Grünenthal accused of kickbacks in Italy Two manufacturers of opioid analgesics – Mundipharma and Grünenthal – have been accused of paying an Italian doctor to promote use of the drugs.
Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.